ALLIANCE PHARMA PLC
APH.L
48.4
1.10
(2.33%)
Market Close
As on 26 Sep, 2023, 04:06 PM
Market Cap
274.46 M
P/E Ratio
24.20
Div Yield
0.02%
Volume
3,955,012.00
Eps
0.02
Previous Close
$47.30
Day Range
46.9 - 49.1
Year Range
34.136 - 73.042
Overall Rating
Strong Sell
Sell
Neutral
Buy
Strong Buy
Zynerba Pharmaceuticals, Inc.
0M40.L
$1.32
Ergomed plc
ERGO.L
-0.62%
$1,344.00
dotdigital Group Plc
DOTD.L
-0.30%
$78.60
Vectura Group plc
VEC.L
-1.75%
$164.80
Photocure ASA
0IMT.L
0.00%
$56.01
iomart Group plc
IOM.L
-9.38%
$160.00
Vetoquinol SA
0O1O.L
0.25%
$77.38
Uniphar plc
UPR.L
-1.48%
$216.00
Kala Pharmaceuticals, Inc.
0JQ2.L
-0.92%
$9.78
Beximco Pharmaceuticals Limited
BXP.L
-7.16%
$37.00
Advanced Medical Solutions Group plc
AMS.L
-7.50%
$196.40
AB Science S.A.
0Q77.L
-0.41%
$2.29
Integrated Diagnostics Holdings plc
IDHC.L
-2.35%
$0.41
GB Group plc
GBG.L
0.00%
$215.00
AB Dynamics plc
ABDP.L
-2.80%
$1,662.50
Boiron SA
0DTF.L
-1.04%
$54.00
Aclaris Therapeutics, Inc.
0H8T.L
0.93%
$6.53
Oxford Biomedica plc
OXB.L
-12.82%
$291.50
Cara Therapeutics, Inc.
0HTC.L
0.34%
$1.74
Benchmark Holdings plc
BMK.L
-2.63%
$37.00
COLTENE Holding AG
0QP7.L
-0.54%
$66.08
Accuray Incorporated
0H8I.L
-0.17%
$2.80
Craneware plc
CRW.L
3.74%
$1,495.50
PureTech Health plc
PRTC.L
0.03%
$200.50
-0.99%
No data
| Payment Date | Dividend | Yield |
|---|---|---|
|
Jan 19, 2023
|
0.592
|
3.387%
|
|
Jul 07, 2022
|
1.128
|
3.344%
|
|
Jan 07, 2022
|
0.563
|
3.264%
|
|
Jul 08, 2021
|
1.074
|
1.593%
|
|
Jan 07, 2021
|
0.536
|
0.795%
|
|
Jan 10, 2020
|
0.536
|
2.245%
|
|
Jul 11, 2019
|
0.977
|
2.172%
|
|
Jan 10, 2019
|
0.487
|
2.04%
|
|
Date
|
Consensus EPS
|
Eps
|
Consensus Revenue
|
Revenue
|
|---|---|---|---|---|
|
Sep 26
|
N/A | N/A | N/A | N/A |
|
Sep 25
|
N/A | N/A | N/A | N/A |
|
Sep 18
|
N/A | N/A | 189.02 M | N/A |
|
Sep 17
|
N/A | N/A | 186.72 M | N/A |
APH.L Profile
Industry:
Drug Manufacturers—Specialty & Generic
Sector:
Healthcare
CEO:
Mr. Andrew Timothy Franklin
Exchange:
London Stock Exchange
London
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.